Table 2.
Antimicrobial susceptibility testing | Antimicrobial resistance genes amplification | ||||
---|---|---|---|---|---|
Drug | S (%) | I (%) | R (%) | Gene | No. of isolates (%) |
β‐lactams | |||||
Penicillin | 62.5 | 0 | 37.5 | blaZ | 1 (6.25) |
Cefoxitin | 93.75 | 0 | 6.25 | mecA | 1 (6.25) |
Cefazolin | 93.75 | 0 | 6.25 | ||
Ceftriaxone | 75.0 | 18.75 | 6.25 | ||
Aminoglycosides | |||||
Gentamicin | 87.5 | 0 | 12.5 | aacA‐ | 1 (6.25) |
Amikacin | 93.75 | 0 | 6.25 | aphD | |
Macrolides | |||||
Azithromycin | 93.75 | 0 | 6.25 | mrs(A) | 1 (6.25) |
Tetracycline | |||||
Doxycycline | 93.75 | 0 | 6.25 | tet(K) | 0 (0) |
Fluoroquinolones | |||||
Ciprofloxacin | 93.75 | 0 | 6.25 | gyrA | 1 (6.25) |
Moxifloxacin | 93.75 | 0 | 6.25 | grlA | 1 (6.25) |
Norfloxacin | 93.75 | 0 | 6.25 | ||
Folate pathway inhibitors | |||||
Trimethoprim/sulfamethoxazole | 100 | 0 | 0 | dfrG | 0 (0) |
Phenicols | |||||
Chloramphenicol | 100 | 0 | 0 | cfr | 0 (0) |
S: susceptible; I: intermediate; R: resistance.